VYNE Therapeutics Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for VYNE, updated each market day.
VYNE AI Sentiment
AI sees no strong directional signal for VYNE Therapeutics Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About VYNE Therapeutics Inc. Common Stock
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.
Sector
Exchange
Market Cap
$20,410,442
Cap Tier
Employees
10
Headquarters
BRIDGEWATER, NJ
Listed Since
Jan. 25, 2018
Website
VYNE Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
VYNE Volatility
VYNE Therapeutics Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
